期刊文献+

37例胃肠道间质瘤预后因素分析 被引量:1

The Clinical Analyses of the Prognosis Factors of 37 Patients with Gastrointestinal Stromal Tumor
下载PDF
导出
摘要 目的探讨影响胃肠道间质瘤(G IST)预后的因素。方法回顾性分析37例G IST患者的免疫组化检测结果及肿瘤大小、生长部位、核分裂数,手术的切除程度与其预后的关系。结果 G IST患者的病理切片中CD117、CD34的阳性表达率分别为97.3%和78.4%。肿瘤直径〉10 cm、5~10 cm者预后较≤5 cm者差(P〈0.05);核分裂数〉5/50 HPF者预后较≤5/50 HPF者差(P〈0.05);行姑息性切除者比行完全性切除者预后差(P〈0.05)。结论完全性切除肿瘤能明显改善G IST患者的预后,肿瘤直径大小和核分裂数是影响预后的因素。 Objective To investigate the prognostic factors of patients with gastrointestinal stromal tumor(GIST).Methods The clinical data of 37 patients with GIST were reviewed retrospectively.The clinicopathologic diagnoses were determined by immunochemistry method.The relationships of the prognoses with tumor size,tumor location,mitotic counts and range of tumor resection were analyzed.Results The positive rates of CD117 and CD34 were 97.3% and 78.4% in the pathological sections of patients with GIST respectively.The patients with tumor size 10 cm and 5-10 cm,mitotic counts 5/50 HPF,incomplete resection had poorer outcome than those of tumor size ≤5 cm,mitotic counts ≤5/50 HPF,complete resection(P0.05).Conclusion Complete resection can improve the prognosis of patients with GIST.Tumor size and tumor mitotic counts are the prognostic factors.
出处 《肿瘤基础与临床》 2011年第2期143-146,共4页 journal of basic and clinical oncology
关键词 胃肠间质瘤 预后 临床分析 gastrointestinal stromal tumor prognosis clinical analysis
  • 相关文献

参考文献10

二级参考文献53

  • 1竺杨文,王跃东,李保军.胃肠道间质瘤的腹腔镜外科治疗[J].外科理论与实践,2004,9(6):506-507. 被引量:8
  • 2孙梅,张兴义,邹洪杰,孙亚欣,李东复.CyclinD1、Ki67和Bcl-2在胃肠道间质瘤的表达及与其预后的关系[J].中华胃肠外科杂志,2005,8(6):542-543. 被引量:6
  • 3Mazur MT, Clark HB. Gatric stromal tumors: reappraisal of histogenesis [J]. Am J Surg Pathol, 1983, 7(6): 507-519.
  • 4Sircar K, Hewlett BR, Huizinga JD, et al. Interstitial cells of Cajal as precursors of gastrointestinal stromal tumors [J]. Am J Surg Pathol, 1999, 23(4): 377-389.
  • 5Jierie JP, Choudry U, Muzikansky A, et al. The effect of surgery and grade on outcome of gastrointestinal stromal tumors [J]. Arch Surg, 2001, 136(4): 383-389.
  • 6Trupiano JK, Stewart RE, Misick C, et al. Gastric stromal tumors: a clinicopathologic study of 77 cases with correlation of features with nonaggressive and aggressive clinical behaviors [J]. Am J Surg Pathol, 2002, 26(6): 705-714.
  • 7Miettinen M, E1-Rifai W, HL Sobin L, et al. Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review [J]. Hum Pathol, 2002, 33(5): 478-483.
  • 8Blanks CD. Therapeutic options for gastrointestinal stromal tumors[C]. Proc ASCO, 2003:266-272.
  • 9Koh JS, Trent J, Chen L, et al. Gastrointestinal stromal tumors: overview of pathologic features, molecular biology, and therapy with imatinib mesylate [J]. Histol Histopathol, 2004, 19(2): 565-574.
  • 10Singer S, Rubin BP, Lux ML, et al. Prognostic value of KIT mutation type, mitotic activity, and histologic subtype in gastrointestinal stromal tumors [J]. J Clin Oncol, 2002, 20 (18): 3898-3905.

共引文献70

同被引文献6

  • 1侯辉,耿小平,刘念,金小顺.胃肠道间质瘤的诊断及外科治疗体会[J].中华普通外科杂志,2007,22(8):564-566. 被引量:11
  • 2Steigen S E, Eide T J. Gastrointestinal stromal tumor: a clini- cal overview [J]. APMIS, 2009, 117 (2): 73-86.
  • 3Gold J S, Dematteo R P. Combined surgical and molecular ther- apy: the gastrointestinal stromal tumor model [J]. Ann Surg, 2006, 244 (2): 176-184.
  • 4Meara R S, Cangiarella J, Simsir A, et al. Prediction of ag- gressiveness of gastrointestinal stromal turnouts based on immu- nostaining with bcl-2, Ki-67 and p53 [J]. Cytopathology, 2007, 18 (5):283-289.
  • 5HsuK H, YangTM, ShanYS, etal. Tumor size isamajor determinant of recurrence in patients with resectable gastrointes- tinal stroraal tumor [J]. Am J Surg, 2007, 194 (2): 148-152.
  • 6卢明东,张毅,郑志强,游涛,俞耀军.胃肠道间质瘤患者预后多因素分析[J].温州医学院学报,2009,39(4):345-348. 被引量:6

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部